Nootropics Depot CEO Calls for Nuanced Approach to Hydration in Whitepaper

Paul Eftang, CEO of Nootropics Depot, recently authored a whitepaper in which he called for the hydration category to promote a more nuanced, use-case-specific approach to electrolyte supplementation.

The World Health Organization (WHO)’s Oral Rehydration Solution (ORS) specifications are designed for severe fluid loss from acute diarrheal dehydration, but this legacy framework shouldn’t be considered a benchmark for contemporary consumer products designed for active lifestyles and everyday usage, he argued.

The paper encourages a more careful and selective evaluation of how electrolyte products are designed, and why different formulations serve different purposes. Core variables, such as sodium content, carbohydrate levels, osmolarity, and broader mineral profile, should each work together to shape the positioning of a hydration formula, Eftang argued; the modern hydration category, however, is crowded with simplified talking points around ‘more sodium’ or ‘faster hydration,’ while product development and consumer education overlooks the finer details, such as how hydration fits in with daily usage, exercise, heat exposure, travel, and more.

The paper provides insights into the formulation of the company’s InfiniLyte, which includes several trace elements not included in the WHO ORS template, like iodine, zinc, copper, manganese, and selenium, which are also depleted from the body during dehydration.

“We believe the hydration category has reached a point where it deserves a more nuanced conversation around formulation,” said Paul Eftang, CEO of Nootropics Depot. “This white paper is meant to look more closely at the assumptions that shape modern electrolyte products, where those assumptions come from, and how brands can think more carefully about designing formulas for actual use contexts. Quality is everything to us, and that includes being willing to question legacy standards when the category has evolved beyond them.”